We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




批准快速链球菌聚合酶链反应用于传统临床实验室以外的检查

By LabMedica International staff writers
Posted on 27 Jul 2015
Print article
图片:Cobas Liat系统设计为一个快速、易用、紧凑的PCR系统(照片由Roche提供)。
图片:Cobas Liat系统设计为一个快速、易用、紧凑的PCR系统(照片由Roche提供)。
Cobas Liat系统是一种耗时15分钟的诊断检查,用于检测咽喉培养物中的甲型链球菌(Strep A),此检查在一种已获得美国食品和药品管理局临床检验改进修正计划(CLIA)豁免的用户友好自动PCR平台上运行。
CLIA豁免允许在非传统实验室地点进行Roche(Basel,Switzerland)cobas Liat系统Strep A检验,包括医师办公室、急诊室、保健诊所、药学临床和其他医疗机构。
Cobs Liat系统是一种快速、易用、紧凑的PCR平台,设计用于床旁按需检查,如医师办公室、药房、以及医院和卫星实验室。此系统配备全自动触摸屏导引操作,操作者需要接受的培训量最少,随时可以使用。该系统包括cobas Liat分析仪——一种小巧的台式分析仪,由一组广泛的仪器保护,并组合了越来越多的检测方法,包括cobas甲型/乙型流感、cobas甲型/乙型流感和RSV,以及Cobas Strep A。
“今天的决定允许在此前依赖快速抗原技术的临床环境中使用cobas Strep A检验,原本使用的技术灵敏度较低,常需要进行确证检验,”Roche Diagnostics的首席运营官,Roland Diggelmann说明。“Cobas Strep A检查大约需要15分钟的时间出具报告,相对于需要使用培养物进行检查要经过数天才能得出结果的情况而言,新的方法改善了患者和专业医疗人员的临床经验。”

Related Links:
Roche 

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Chlamydia Trachomatis Assay
Chlamydia Trachomatis IgG
New
Herpes Simplex Virus ELISA
HSV 2 IgG – ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.